FindTrial
Sign In

Prognostic ability of Hematocrit to Albumin ratio in Acute Pancreatitis Patient

A Prospective Observational study on Prognostic ability of Hematocrit to Albumin ratio in Acute Pancreatitis Patient - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090110
Enrollment
173
Registered
2025-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K85- Acute pancreatitis

Interventions

Control Intervention1: Nil: Nil

Sponsors

DrArjun MH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with acute pancreatitis based on the 2012 revised Atlanta Classification Patient who provide informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patient diagnosed with acute pancreatitis with significant unrelated complication (e.g. Nephrotic syndrome, CLD) Patient with severe life threatening conditions (e.g.CKD STAGE 5,Malignancy) Patient diagnosed with chronic pancreatitis or a history of recurrent pancreatitis

Design outcomes

Primary

MeasureTime frame
Determine the relationship between Hematocrit to albumin ratio and severity of acute pancreatitisTimepoint: 1 years and 7 months—

Secondary

MeasureTime frame
Asses hematocrit to albumin ratio are associated with clinical outcomes, including complications and mortality rate.Timepoint: 1 years 7 months;Analyze the incidence of complications(e.g., necrosis, infection, organ failure)in relation to the hematocrit to albumin ratio and insight their roles as potential biomarkers for complications.Timepoint: 1 year 7 months—

Countries

India

Contacts

Public ContactDr Arjun MH

Kasturba Medical College

Prasad.ss@manipal.edu8073680789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026